Streetbeat News

Equity Actions

BKNG

A significant bearish stance has been taken on Booking Holdings (NASDAQ:BKNG) by a large investor or institution, as indicated by unusual options activity. The sentiment among these big-money traders is 5% bullish and 94% bearish. Whales have been targeting a price range from $2300.0 to $3500.0 for Booking Holdings over the last 3 months. The price of BKNG is currently down -1.54% at $2678.81. Wedbush and Wells Fargo have downgraded their actions on BKNG with price targets of $3060 and $2257 respectively.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 6:31 pm

TSLA

Elon Musk confirmed that Bill Gates had a short position on Tesla (TSLA) stock. Despite Tesla's shares falling over 60% in 2022, an investor who bet against Gates and invested $1,000 in Tesla when Musk revealed Gates' short position would have seen a 4.3% return, with the investment worth $1,043.27 today. The return could have been as high as 53.3% if the investment was timed correctly.

Portfolio Pulse from Chris Katje

July 05, 2023 | 6:27 pm

Credit Suisse analyst Ariel Rosa has reiterated a Neutral rating on Canadian Pacific Kansas City Ltd (CPKC) and raised the price target from $81 to $87. CPKC expects to achieve mid-single-digit EPS growth in 2023 and double-digit annual EPS growth over 2024-28. However, the analyst warns that CPKC's high valuation premium and the need for significant operating margin improvement over the next 3 years call for caution.

Portfolio Pulse from Shivani Kumaresan

July 05, 2023 | 6:16 pm

A whale investor has taken a bullish stance on Citigroup (NYSE:C), with 58% of investors opening trades with bullish expectations and 41% with bearish. The whale has been targeting a price range from $30.0 to $50.0 for Citigroup over the last 3 months. Wells Fargo maintains an Overweight rating on Citigroup with a price target of $60, while RBC Capital and Morgan Stanley have downgraded their actions to Outperform and Underweight respectively, with price targets of $51 and $45.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 6:16 pm

CRM

A significant bearish stance has been taken on Salesforce (NYSE:CRM) by a large investor, as indicated by unusual options activity. The overall sentiment of these big-money traders is split between 39% bullish and 60% bearish. The price of CRM is up 1.02% at $213.8. Piper Sandler and RBC Capital have downgraded their actions on Salesforce with price targets of $248 and $240 respectively.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 6:16 pm

AAP

APTV

ASO

HELE

LEN

LULU

RIVN

TSLA

Benzinga's options activity scanner has identified significant options activity in the Consumer Discretionary sector. Notable trades include bullish call options for TSLA, RIVN, LI, AAP, ASO, LEN, APTV, and HELE, and a bearish put option for LULU. The trades vary in expiration dates and strike prices.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 5:39 pm

NASDAQ:FLGC

OTCQB:CBWTF

OTCQX:ACRHF

OTCQX:DLTNF

OTCQX:GLASF

OTCQX:MEDIF

TSXV:HMPG

TSXV:ZYUS

Several cannabis companies have announced leadership changes. The Hempshire Group and ZYUS Life Sciences Corp. reported board changes. Glass House Brands, MediPharm Labs Corp., Auxly Cannabis Group, and Delta 9 Cannabis Inc. announced results from their annual meetings, electing new board directors. Würk, Flora Growth Corp., Acreage Holdings, and Ally Biotech have also made key appointments.

Portfolio Pulse from Jelena Martinovic

July 05, 2023 | 5:25 pm

UPS

A 'whale' investor has taken a bullish stance on United Parcel Service (UPS), with 50% of investors opening trades with bullish expectations and 50% with bearish. The total amount for puts is $891,760 and for calls is $80,118. Whales have been targeting a price range from $170.0 to $185.0 for UPS over the last 3 months. The price of UPS is currently down -2.05% at $180.0. Atlantic Equities downgraded its action to Neutral with a price target of $162.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 5:16 pm

MRNA

Moderna Inc (NASDAQ:MRNA) has reportedly signed a deal with Chinese authorities to research, develop, and manufacture mRNA medicines in China. This agreement represents Moderna's first for developing mRNA medicines, not just COVID vaccines. The company has signed a memorandum of understanding and a related land collaboration agreement to develop drugs intended exclusively for the Chinese market. The size of the deal remains undisclosed, but it follows news that Moderna is planning its first investment in China, potentially valued at around $1 billion.

Portfolio Pulse from Vandana Singh

July 05, 2023 | 5:06 pm

A significant bullish stance on Boeing (NYSE:BA) has been observed through unusual options activity. The sentiment among these big-money traders is split evenly between bullish and bearish. The whales have been targeting a price range from $145.0 to $235.0 for Boeing over the last 3 months. Currently, the price of BA is up 1.32% at $213.7. Bernstein and RBC Capital have downgraded their actions on Boeing with price targets of $252 and $220 respectively.

Portfolio Pulse from Benzinga Insights

July 05, 2023 | 4:46 pm